Utama › Glioblastoma › North Carolina › Durham
Kajian klinikal Glioblastoma di Durham, NC
20 kajian untuk Glioblastoma sedang mencari peserta di lokasi dalam dan sekitar Durham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Mengambil pesertaFasa 3
- University of North Carolina, Chapel Hill · 10 mi jauh
Targeted Pediatric High-Grade Glioma Therapy
Mengambil pesertaKajian pemerhatian
- Duke University Health System, Durham
Study of Olutasidenib and Temozolomide in HGG
Mengambil pesertaFasa 2
- Duke University Health System, Durham
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Mengambil pesertaFasa 3
- Duke Cancer Institute, Durham
BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma
Mengambil pesertaFasa 1
- Duke University Medical Center, Durham
Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
Mengambil pesertaFasa 2
- Duke University Medical Center, Durham
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
Mengambil pesertaFasa 2
- Duke University, Durham
A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
Mengambil pesertaFasa 2
- Duke University, Durham
Lerapolturev (PVSRIPO) in GBM
Mengambil pesertaFasa 2
- Duke University Medical Center, Durham
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Mengambil pesertaFasa 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
- Duke University Health System, Durham
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
Mengambil pesertaFasa 1
- Duke University Medical Center, Durham
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Mengambil pesertaFasa 2
- Duke University Health System, Durham
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Mengambil pesertaFasa 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauh
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
Mengambil pesertaKajian pemerhatian
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi jauh
D2C7-IT + 2141-V11 Combination Post-resection in rGBM
Mengambil pesertaFasa 1
- Duke University Medical Center, Durham
D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients
Mengambil pesertaFasa 1/2
- Duke University Medical Center, Durham
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Mengambil pesertaFasa 2
- University of North Carolina, Chapel Hill · 10 mi jauh
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Mengambil pesertaFasa 1
- Duke University, Durham
Kajian Glioblastoma di bandar lain
- New York City, NY30 kajian
- Boston, MA28 kajian
- Houston, TX26 kajian
- Los Angeles, CA24 kajian
- San Francisco, CA17 kajian
- Chicago, IL15 kajian
- Washington, DC15 kajian
- Columbus, OH14 kajian
- Miami, FL14 kajian
- Rochester, MN13 kajian
- Jacksonville, FL13 kajian
- Aurora, CO12 kajian
Kajian lain di Durham
- Kanser Payudara64 kajian
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil39 kajian
- Mieloma Pelbagai37 kajian
- Leukemia Mieloid Akut33 kajian
- Kanser Metastatik33 kajian
- Kanser Prostat32 kajian
- Kanser Paru-paru32 kajian
- Kanser Kolorektal28 kajian
- Kanser Ovari27 kajian
- Leukemia Limfositik Kronik27 kajian
- Kegagalan Jantung26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.